{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T22:24:44Z","timestamp":1794349484430,"version":"4.9.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012399","name":"Biomedical Advanced Research and Development Authority","doi-asserted-by":"publisher","award":["75A50120C00001"],"award-info":[{"award-number":["75A50120C00001"]}],"id":[{"id":"10.13039\/100012399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.eclinm.2025.103656","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T01:24:45Z","timestamp":1763688285000},"page":"103656","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Omadacycline versus moxifloxacin for community-acquired bacterial pneumonia (OPTIC-2): a phase 3b, randomised, double-blind, multicentre, controlled, noninferiority trial"],"prefix":"10.1016","volume":"90","author":[{"suffix":"Jr.","given":"Thomas M.","family":"File","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2051-1732","authenticated-orcid":false,"given":"Keith S.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Skliarov","family":"Ihor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2572-6353","authenticated-orcid":false,"given":"Iryna","family":"Hovbakh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vakhtang","family":"Katsarava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Kirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karan","family":"Soni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kushagra","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Manley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H.","family":"Deck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9356-8223","authenticated-orcid":false,"given":"Diane","family":"Anastasiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surya","family":"Chitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Villano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2025.103656_bib1","series-title":"NUZYRA [package insert]","year":"2021"},{"issue":"Suppl 1","key":"10.1016\/j.eclinm.2025.103656_bib2","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1093\/cid\/ciz395","article-title":"Microbiology and preclinical review of omadacycline","volume":"69","author":"Karlowsky","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.eclinm.2025.103656_bib3","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJMoa1800201","article-title":"Omadacycline for community-acquired bacterial pneumonia","volume":"380","author":"Stets","year":"2019","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.eclinm.2025.103656_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241311038","article-title":"The global burden of community-acquired pneumonia in adults, encompassing invasive pneumococcal disease and the prevalence of its associated cardiovascular events, with a focus on pneumolysin and macrolide antibiotics in pathogenesis and therapy","volume":"24","author":"Anderson","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.eclinm.2025.103656_bib5","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1056\/NEJMcp2303286","article-title":"Community-acquired pneumonia","volume":"389","author":"File","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2025.103656_bib6","series-title":"Overview of operating room procedures during inpatient stays in U.S. hospitals, 2018","author":"McDermott","year":"2006"},{"key":"10.1016\/j.eclinm.2025.103656_bib7","author":"Murphy"},{"issue":"9998","key":"10.1016\/j.eclinm.2025.103656_bib8","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0140-6736(15)60733-4","article-title":"Community-acquired pneumonia","volume":"386","author":"Prina","year":"2015","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.eclinm.2025.103656_bib9","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.emc.2018.07.001","article-title":"Community-acquired pneumonia","volume":"36","author":"Rider","year":"2018","journal-title":"Emerg Med Clin North Am"},{"issue":"6","key":"10.1016\/j.eclinm.2025.103656_bib11","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00134-023-07033-8","article-title":"ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of severe community-acquired pneumonia","volume":"49","author":"Martin-Loeches","year":"2023","journal-title":"Intensive Care Med"},{"issue":"7","key":"10.1016\/j.eclinm.2025.103656_bib12","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.eclinm.2025.103656_bib13","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac420","article-title":"A multicenter evaluation of trends in antimicrobial resistance among Streptococcus pneumoniae isolates from adults in the United States","volume":"9","author":"Mohanty","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103656_bib14","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa065","article-title":"Antibiotic treatment failure and associated outcomes among adult patients with community-acquired pneumonia in the outpatient setting: a real-world US insurance claims database study","volume":"7","author":"Tillotson","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"10","key":"10.1016\/j.eclinm.2025.103656_bib15","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/cid\/cix549","article-title":"Evolving understanding of the causes of pneumonia in adults, with special attention to the role of pneumococcus","volume":"65","author":"Musher","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eclinm.2025.103656_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1225710","article-title":"Omadacycline in the treatment of community-acquired bacterial pneumonia in patients with comorbidities: a post-hoc analysis of the phase 3 OPTIC trial","volume":"10","author":"Rodriguez","year":"2023","journal-title":"Front Med"},{"key":"10.1016\/j.eclinm.2025.103656_bib17","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jgar.2021.09.011","article-title":"Surveillance of omadacycline activity tested against clinical isolates from the USA: report from the SENTRY antimicrobial surveillance program, 2019","volume":"27","author":"Pfaller","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"issue":"9","key":"10.1016\/j.eclinm.2025.103656_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae470","article-title":"High rates of nonsusceptibility to common oral antibiotics in Streptococcus pneumoniae clinical isolates from the United States (2019-2021)","volume":"11","author":"Deshpande","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103656_bib19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s40261-021-01005-w","article-title":"Decision analysis: omadacycline relative to moxifloxacin among hospitalized community-acquired bacterial pneumonia patients at risk of Clostridioides difficile infection","volume":"41","author":"Lodise","year":"2021","journal-title":"Clin Drug Investig"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537025005905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537025005905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:40:22Z","timestamp":1794346822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537025005905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":18,"alternative-id":["S2589537025005905"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103656","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Omadacycline versus moxifloxacin for community-acquired bacterial pneumonia (OPTIC-2): a phase 3b, randomised, double-blind, multicentre, controlled, noninferiority trial","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103656","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103656"}}